Toshio Fujimoto, MD, MBA, joined as the General Manager of Takeda Pharmaceutical Company Ltd.'s Health Innovation Park in Shonan in December, 2017 from Eli Lilly and Company.
"Shonan Health Innovation Park (iPark)" was launched in April, 2018 under his operation. In this role as the General Manager of iPark, Dr. Fujimoto provides strategic leadership and oversight for all key iPark activities, including: development and execution of business and financial plans, coordination
of site operations and services, tenant recruitment and management, and marketing and public relations activities.
Dr. Fujimoto received his MD from Kyoto University and his MBA from Kobe University. He began his clinical practice as a Resident at the Department of Thoracic Surgery at Kyoto University Hospital.
After completing several rotations at local area hospitals, he took a position in Germany as an Assistant Surgeon with the Thoracic Surgery Department at Ruhrlandklink Hospital, and later moved to the U.S. to serve as Clinical Fellow, General Thoracic Surgery at the Mayo Clinic. He experienced over 10 years
2017 - Takeda Pharmaceutical Company, Shonan Health Innovation Park- General Manager
2006 – 2017 Eli Lily & Company (2015 – Vice President, Medicine Development Unit Japan)
2005 – 2006 Shizuoka City Hospital- Consultant, Thoracic Surgery
2004 – 2005 Mayo Clinic, Rochester- Clinical Fellow, General Thoracic Surgery, USA
2003 – 2004 University Hospital of Freiburg, Assistant Surgeon, Thoracic Surgery, Germany
2001 – 2003 Kyoto Katsura Hospital- Consultant, Respiratory Disease Centre
1999 – 2001 Ruhrlandklinik- Assistant Surgeon, Thoracic Surgery, Germany
1994 – 1999 Kyoto University Hospital, Thoracic Surgery (residency training in the affiliated hospitals at
Kyoto Katsura Hospital and Fukui Red Cross Hospital)
President of the Republic of Iceland